Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID Reference, 4th edition, 372 pages

+ the daily Top 10

  Colorectal Neoplasms

  Free Subscription

Articles published in J Surg Oncol

Retrieve available abstracts of 151 articles:
HTML format

Single Articles

    September 2020
  1. RAJ KUMAR B, Pandey D, Rohila J, deSouza A, et al
    An observational study of the demographic and treatment changes in a tertiary colorectal cancer center during the COVID-19 pandemic.
    J Surg Oncol. 2020 Sep 3. doi: 10.1002/jso.26193.
    PubMed     Abstract available

  2. KAWAKATSU S, Mise Y, Hiratsuka M, Inoue Y, et al
    Clinical significance of subcentimeter pulmonary nodules in patients undergoing hepatectomy for colorectal liver metastases.
    J Surg Oncol. 2020;122:523-528.
    PubMed     Abstract available

    August 2020
  3. PARK Y, Kim DW, Hong YJ, Park KU, et al
    Is elevated microsatellite alterations at selected tetranucleotide repeats (EMAST)-negative/MSI-high colorectal cancer a distinct subtype of the disease?
    J Surg Oncol. 2020 Aug 10. doi: 10.1002/jso.26157.
    PubMed     Abstract available

  4. SEBASTIAN-TOMAS JC, Domingo-Del Pozo C, Gomez-Abril SA, Navarro-Martinez S, et al
    Laparoscopic staged colon-first resection for metastatic colorectal cancer: Perioperative and midterm outcomes from a single-center experience.
    J Surg Oncol. 2020 Aug 10. doi: 10.1002/jso.26152.
    PubMed     Abstract available

  5. BELLI F, Sorrentino L, Gallino G, Gronchi A, et al
    A proposal of an updated classification for pelvic relapses of rectal cancer to guide surgical decision-making.
    J Surg Oncol. 2020;122:350-359.
    PubMed     Abstract available

  6. FERNANDEZ-MORENO MC, Dorcaratto D, Garces-Albir M, Munoz E, et al
    Impact of type and severity of postoperative complications on long-term outcomes after colorectal liver metastases resection.
    J Surg Oncol. 2020;122:212-225.
    PubMed     Abstract available

    July 2020
    Minimally invasive rectal surgery: Laparoscopy, robotics, and transanal approaches.
    J Surg Oncol. 2020;122:78-84.

  8. THIELS CA, D'Angelica MI
    Hepatic artery infusion pumps.
    J Surg Oncol. 2020;122:70-77.
    PubMed     Abstract available

    June 2020
  9. BINGMER K, Ofshteyn A, Bliggenstorfer JT, Kethman W, et al
    Primary tumor location impacts survival in colorectal cancer patients after resection of liver metastases.
    J Surg Oncol. 2020 Jun 10. doi: 10.1002/jso.26061.
    PubMed     Abstract available

  10. BINGMER K, Kondray V, Ofshteyn A, Bliggenstorfer JT, et al
    Sarcopenia is associated with worse overall survival in patients with anal squamous cell cancer.
    J Surg Oncol. 2020;121:1148-1153.
    PubMed     Abstract available

  11. YANG J, Chen Q, Jindou L, Cheng Y, et al
    The influence of anastomotic leakage for rectal cancer oncologic outcome: A systematic review and meta-analysis.
    J Surg Oncol. 2020;121:1283-1297.
    PubMed     Abstract available

  12. SROUJI R, Narayan R, Boerner T, Buisman F, et al
    Addition of adjuvant hepatic artery infusion to systemic chemotherapy following resection of colorectal liver metastases is associated with reduced liver-related mortality.
    J Surg Oncol. 2020;121:1314-1319.
    PubMed     Abstract available

  13. STEIN MK, Williard FW, Xiu J, Tsao MW, et al
    Comprehensive tumor profiling reveals unique molecular differences between peritoneal metastases and primary colorectal adenocarcinoma.
    J Surg Oncol. 2020;121:1320-1328.
    PubMed     Abstract available

    May 2020
  14. SORRENTINO L, Guaglio M, Cosimelli M
    Elective colorectal cancer surgery at the oncologic hub of Lombardy inside a pandemic COVID-19 area.
    J Surg Oncol. 2020 May 31. doi: 10.1002/jso.26052.

  15. RUEFF J, Weixler B, Viehl CT, Ochsner A, et al
    Improved quality of colon cancer surveillance after implementation of a personalized surveillance schedule.
    J Surg Oncol. 2020 May 14. doi: 10.1002/jso.25973.
    PubMed     Abstract available

  16. FIELDS AC, Lu PW, Yoo J, Irani J, et al
    Treatment of stage I-III rectal cancer: Who is refusing surgery?
    J Surg Oncol. 2020;121:990-1000.
    PubMed     Abstract available

    April 2020
  17. MIYAMOTO Y, Hiyoshi Y, Tokunaga R, Akiyama T, et al
    Postoperative complications are associated with poor survival outcome after curative resection for colorectal cancer: A propensity-score analysis.
    J Surg Oncol. 2020 Apr 28. doi: 10.1002/jso.25961.
    PubMed     Abstract available

  18. VAZ DA SILVA DG, Ribeiro HSC, Arra DASM, Torres SM, et al
    Predictors of long-term survival in patients with hepatic resection of colorectal metastases: Analysis of a Brazilian Cancer Center Cohort.
    J Surg Oncol. 2020;121:893-900.
    PubMed     Abstract available

  19. ARAUJO RLC, Sanctis MA, Barroti LC, Coelho TRV, et al
    Robotic approach as a valid strategy to improve the access to posterosuperior hepatic segments-Case series and review of literature.
    J Surg Oncol. 2020;121:873-880.
    PubMed     Abstract available

  20. RIBEIRO R, Fontes Cintra G, Barrozo A, Tieko Tsunoda A, et al
    Brazilian Society of Surgical Oncology guidelines for surgical treatment of endometrial cancer in regions with limited resources.
    J Surg Oncol. 2020;121:730-742.
    PubMed     Abstract available

  21. ARAUJO RLC, Milani JM, Armentano DP, Moreira RB, et al
    Disappearing colorectal liver metastases: Strategies for the management of patients achieving a radiographic complete response after systemic chemotherapy.
    J Surg Oncol. 2020;121:848-856.
    PubMed     Abstract available

  22. WOESTE MR, Philips P, Egger ME, Scoggins CR, et al
    Optimal perfusion chemotherapy: A prospective comparison of mitomycin C and oxaliplatin for hyperthermic intraperitoneal chemotherapy in metastatic colon cancer.
    J Surg Oncol. 2020 Apr 1. doi: 10.1002/jso.25920.
    PubMed     Abstract available

    March 2020
  23. LU PW, Fields AC, Yoo J, Irani J, et al
    Sociodemographic predictors of surgery refusal in patients with stage I-III colon cancer.
    J Surg Oncol. 2020 Mar 29. doi: 10.1002/jso.25917.
    PubMed     Abstract available

  24. YUCE TK, Ellis RJ, Chung J, Merkow RP, et al
    Association between surgical approach and survival following resection of abdominopelvic malignancies.
    J Surg Oncol. 2020;121:620-629.
    PubMed     Abstract available

    February 2020
  25. CORSINI EM, Datar SS, Mitchell KG, Zhou N, et al
    High mutational concordance between primary colorectal tumors and associated pulmonary metastases.
    J Surg Oncol. 2020 Feb 19. doi: 10.1002/jso.25871.
    PubMed     Abstract available

  26. SERRANO PE, Gu CS, Moulton CA, Husien M, et al
    Effect of PET-CT on disease recurrence and management in patients with potentially resectable colorectal cancer liver metastases. Long-term results of a randomized controlled trial.
    J Surg Oncol. 2020 Feb 7. doi: 10.1002/jso.25864.
    PubMed     Abstract available

    December 2019
  27. LEIPHRAKPAM PD, Lazenby AJ, Chowdhury S, Smith LM, et al
    Prognostic and therapeutic implications of NHERF1 expression and regulation in colorectal cancer.
    J Surg Oncol. 2019 Dec 22. doi: 10.1002/jso.25805.
    PubMed     Abstract available

  28. LIMA PMA, Torres LC, Martins MR, da Matta MC, et al
    Soluble levels of sCD40L and s4-1BB are associated with a poor prognosis in elderly patients with colorectal cancer.
    J Surg Oncol. 2019 Dec 19. doi: 10.1002/jso.25813.
    PubMed     Abstract available

  29. GOFFREDO P, Zhou P, Ginader T, Hrabe J, et al
    Positive circumferential resection margins following locally advanced colon cancer surgery: Risk factors and survival impact.
    J Surg Oncol. 2019 Dec 18. doi: 10.1002/jso.25801.
    PubMed     Abstract available

  30. GKEKAS I, Novotny J, Fabian P, Nemecek R, et al
    Mismatch repair status predicts survival after adjuvant treatment in stage II colon cancer patients.
    J Surg Oncol. 2019 Dec 11. doi: 10.1002/jso.25798.
    PubMed     Abstract available

  31. FIELDS AC, Welten VM, Lu P, Goldberg JE, et al
    Does race impact survival for patients with anal squamous cell carcinoma?
    J Surg Oncol. 2019;120:1201-1207.
    PubMed     Abstract available

  32. YANG L, Bao J, Jiang Q, Yu DS, et al
    Lower fecal pH may be a novel indicator of pouchitis after IPAA in patients with FAP or metachronous Lynch syndrome.
    J Surg Oncol. 2019;120:1184-1189.
    PubMed     Abstract available

  33. REYNOLDS IS, O'Connell E, Fichtner M, McNamara DA, et al
    Mucinous adenocarcinoma of the colon and rectum: A genomic analysis.
    J Surg Oncol. 2019;120:1427-1435.
    PubMed     Abstract available

  34. KIM JC, Lee JL, Kim CW, Lim SB, et al
    Mechanotechnical faults and particular issues of anastomotic complications following robot-assisted anterior resection in 968 rectal cancer patients.
    J Surg Oncol. 2019;120:1436-1445.
    PubMed     Abstract available

  35. XIAO C, Zhou M, Yang X, Xiao F, et al
    Novel nomogram with microvascular density in the surgical margins can accurately predict the risk for anastomotic leakage after anterior resection for rectal cancer.
    J Surg Oncol. 2019;120:1412-1419.
    PubMed     Abstract available

    November 2019
  36. SHARMA A, Alatise OI, Adisa AO, Arowolo OA, et al
    Treatment of colorectal cancer in Sub-Saharan Africa: Results from a prospective Nigerian hospital registry.
    J Surg Oncol. 2019 Nov 19. doi: 10.1002/jso.25768.
    PubMed     Abstract available

  37. MACARI D, Kawak S, Raofi V, Wasvary H, et al
    Recurrence pattern and outcomes in T4 colon cancer: A single institution analysis.
    J Surg Oncol. 2019 Nov 14. doi: 10.1002/jso.25766.
    PubMed     Abstract available

  38. GAMBOA AC, Liu Y, Lee RM, Zaidi MY, et al
    A novel preoperative risk score to predict lymph node positivity for rectal neuroendocrine tumors: An NCDB analysis to guide operative technique.
    J Surg Oncol. 2019;120:932-939.
    PubMed     Abstract available

  39. CORSINI EM, Mitchell KG, Antonoff MB
    Response to letter to the editor.
    J Surg Oncol. 2019;120:1051-1052.

  40. POLI EC, Millis AM, Berger Y, Sherman SK, et al
    Implementation of bundled care to reduce surgical site infections after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
    J Surg Oncol. 2019;120:1044-1045.

    October 2019
  41. LAPORTE GA, Leguisamo NM, Gloria HCE, Azambuja DB, et al
    The role of double-strand break repair, translesion synthesis, and interstrand crosslinks in colorectal cancer progression-clinicopathological data and survival.
    J Surg Oncol. 2019 Oct 25. doi: 10.1002/jso.25737.
    PubMed     Abstract available

  42. ROLFF HC, Christensen IJ, Svendsen LB, Wilhelmsen M, et al
    The concentration of the cleaved suPAR forms in pre- and postoperative plasma samples improves the prediction of survival in colorectal cancer: A nationwide multicenter validation and discovery study.
    J Surg Oncol. 2019 Oct 23. doi: 10.1002/jso.25733.
    PubMed     Abstract available

  43. SERRANO PE, Gu CS, Husien M, Jalink D, et al
    Risk factors for survival following recurrence after first liver resection for colorectal cancer liver metastases.
    J Surg Oncol. 2019 Oct 14. doi: 10.1002/jso.25735.
    PubMed     Abstract available

  44. HEALY MA, Thirumurthi S, You YN
    Screening high-risk populations for colon and rectal cancers.
    J Surg Oncol. 2019;120:858-863.
    PubMed     Abstract available

    September 2019
  45. FIELDS AC, Lu P, Goldberg J, Irani J, et al
    The role of adjuvant chemotherapy in stage II and III mucinous colon cancer.
    J Surg Oncol. 2019 Sep 19. doi: 10.1002/jso.25705.
    PubMed     Abstract available

  46. LEIJSSEN LGJ, Dinaux AM, Kunitake H, Bordeianou LG, et al
    The impact of postoperative morbidity on survival in patients with metastatic colon and rectal cancer.
    J Surg Oncol. 2019;120:460-472.
    PubMed     Abstract available

  47. GHIASLOO M, Kahya H, Van Langenhove S, Grammens J, et al
    Effect of treatment sequence on survival in stage IV rectal cancer with synchronous and potentially resectable liver metastases.
    J Surg Oncol. 2019;120:415-422.
    PubMed     Abstract available

  48. MAGUIRE LH, Geiger TM, Hardiman KM, Regenbogen SE, et al
    Surgical management of primary colonic lymphoma: Big data for a rare problem.
    J Surg Oncol. 2019;120:431-437.
    PubMed     Abstract available

  49. KYANG LS, Alzahrani NA, Valle SJ, Rahman MK, et al
    Long-term survival outcomes of cytoreductive surgery and perioperative intraperitoneal chemotherapy: Single-institutional experience with 1225 cases.
    J Surg Oncol. 2019;120:794-802.
    PubMed     Abstract available

  50. STUART E, Banerjee S, de la Torre J, Wang Y, et al
    Frequent rectal gastrointestinal stromal tumor recurrences in the imatinib era: Retrospective analysis of an International Patient Registry.
    J Surg Oncol. 2019;120:715-721.
    PubMed     Abstract available

    August 2019
  51. CHEN B
    Colorectal cancer mutations are associated with survival and recurrence after pulmonary metastasectomy.
    J Surg Oncol. 2019 Aug 26. doi: 10.1002/jso.25687.

  52. SAITO G, Sadahiro S, Ogimi T, Miyakita H, et al
    Preventive effects of a synthetic absorbable antiadhesive film (seprafilm) on small bowel obstruction in patients who underwent elective surgery for colon cancer: A randomized controlled trial.
    J Surg Oncol. 2019 Aug 7. doi: 10.1002/jso.25664.
    PubMed     Abstract available

  53. HUGHES BD, Hancock KJ, Shan Y, Thakker RA, et al
    Cost of benign versus oncologic colon resection among fee-for-service Medicare enrollees.
    J Surg Oncol. 2019;120:280-286.
    PubMed     Abstract available

  54. FIELDS AC, Melnitchouk N, Senturk J, Irani J, et al
    Early versus late salvage abdominoperineal resection for anal squamous cell carcinoma: Is there a difference in survival?
    J Surg Oncol. 2019;120:287-293.
    PubMed     Abstract available

  55. BAUSYS A, Kuliavas J, Dulskas A, Kryzauskas M, et al
    Early versus standard closure of temporary ileostomy in patients with rectal cancer: A randomized controlled trial.
    J Surg Oncol. 2019;120:294-299.
    PubMed     Abstract available

  56. HARDIMAN KM, Antunez AG, Kanters A, Schuman AD, et al
    Clinical and pathological outcomes of induction chemotherapy before neoadjuvant radiotherapy in locally-advanced rectal cancer.
    J Surg Oncol. 2019;120:308-315.
    PubMed     Abstract available

    July 2019
  57. DUMONT F, Munoz MA, De Franco V, Wernert R, et al
    Significance of lymph node involvement in local recurrence of colorectal cancer.
    J Surg Oncol. 2019 Jul 22. doi: 10.1002/jso.25631.
    PubMed     Abstract available

  58. CORSINI EM, Mitchell KG, Mehran RJ, Rice DC, et al
    Colorectal cancer mutations are associated with survival and recurrence after pulmonary metastasectomy.
    J Surg Oncol. 2019 Jul 9. doi: 10.1002/jso.25630.
    PubMed     Abstract available

    June 2019
  59. STELZNER S, Radulova-Mauersberger O, Zschuppe E, Kittner T, et al
    Prognosis in patients with synchronous colorectal cancer metastases after complete resection of the primary tumor and the metastases.
    J Surg Oncol. 2019 Jun 5. doi: 10.1002/jso.25578.
    PubMed     Abstract available

  60. LEMOINE L, Thijssen E, Carleer R, Geboers K, et al
    Body surface area-based vs concentration-based perioperative intraperitoneal chemotherapy after optimal cytoreductive surgery in colorectal peritoneal surface malignancy treatment: COBOX trial.
    J Surg Oncol. 2019;119:999-1010.
    PubMed     Abstract available

  61. RAUSA E, Bianco F, Kelly ME, Aiolfi A, et al
    Systemic review and network meta-analysis comparing minimal surgical techniques for rectal cancer: quality of total mesorectum excision, pathological, surgical, and oncological outcomes.
    J Surg Oncol. 2019;119:987-998.
    PubMed     Abstract available

  62. MESQUITA-NETO JWB, Mouzaihem H, Macedo FIB, Heilbrun LK, et al
    Perioperative and oncological outcomes of abdominoperineal resection in the prone position vs the classic lithotomy position: A systematic review with meta-analysis.
    J Surg Oncol. 2019;119:979-986.
    PubMed     Abstract available

    May 2019
  63. KIM HS, Kim KM, Lee SB, Kim GR, et al
    Clinicopathological and biomolecular characteristics of stage IIB/IIC and stage IIIA colon cancer: Insight into the survival paradox.
    J Surg Oncol. 2019 May 27. doi: 10.1002/jso.25515.
    PubMed     Abstract available

  64. LORIMER PD, Motz BM, Kirks RC, Han Y, et al
    Frequency of unplanned surgery in patients with stage IV colorectal cancer receiving palliative chemotherapy with an intact primary: An analysis of SEER-Medicare.
    J Surg Oncol. 2019 May 18. doi: 10.1002/jso.25508.
    PubMed     Abstract available

    April 2019
  65. LINO-SILVA LS, Anchondo-Nunez P, Chit-Huerta A, Aguilar-Romero E, et al
    Stage I-III colon cancer patients with tumor deposits behave similarly to stage IV patients. Cross-section analysis of 392 patients.
    J Surg Oncol. 2019 Apr 24. doi: 10.1002/jso.25482.
    PubMed     Abstract available

  66. ANTONY P, Harnoss JC, Warschkow R, Schmied BM, et al
    Urgent surgery in colon cancer has no impact on survival.
    J Surg Oncol. 2019 Apr 12. doi: 10.1002/jso.25469.
    PubMed     Abstract available

  67. LINECKER M, Kuemmerli C, Clavien PA, Petrowsky H, et al
    Dealing with insufficient liver remnant: Associating liver partition and portal vein ligation for staged hepatectomy.
    J Surg Oncol. 2019;119:604-612.
    PubMed     Abstract available

  68. KAWAGUCHI Y, Lillemoe HA, Vauthey JN
    Dealing with an insufficient future liver remnant: Portal vein embolization and two-stage hepatectomy.
    J Surg Oncol. 2019;119:594-603.
    PubMed     Abstract available

  69. KRELL RW, D'Angelica MI
    Treatment sequencing for simultaneous colorectal liver metastases.
    J Surg Oncol. 2019;119:583-593.
    PubMed     Abstract available

  70. PHILLIPS JD, Hasson RM
    Surgical management of colorectal lung metastases.
    J Surg Oncol. 2019;119:629-635.
    PubMed     Abstract available

  71. DAY RW, Aloia TA
    Enhanced recovery in liver surgery.
    J Surg Oncol. 2019;119:660-666.
    PubMed     Abstract available

  72. MARGONIS GA, Kreis ME, Wolfgang CL, Weiss MJ, et al
    Mutation status and surgical selection.
    J Surg Oncol. 2019;119:616-622.
    PubMed     Abstract available

    March 2019
  73. ENG OS, Turaga KK
    Cytoreduction and hyperthermic intraperitoneal chemotherapy in metastatic colorectal cancer.
    J Surg Oncol. 2019 Mar 10. doi: 10.1002/jso.25438.
    PubMed     Abstract available

  74. ADVANI S, Kopetz S
    Ongoing and future directions in the management of metastatic colorectal cancer: Update on clinical trials.
    J Surg Oncol. 2019 Mar 10. doi: 10.1002/jso.25441.
    PubMed     Abstract available

  75. ALZAHRANI NA, Valle SJ, Fisher OM, Sugarbaker PH, et al
    Iterative cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases: A multi-institutional experience.
    J Surg Oncol. 2019;119:336-346.
    PubMed     Abstract available

  76. PENCOVICH N, Houli R, Lubezky N, Goykhman Y, et al
    R1 resection of colorectal liver metastasis - What is the cost of marginal resection?
    J Surg Oncol. 2019;119:347-354.
    PubMed     Abstract available

  77. CHAPMAN BC, Goodman K, Hosokawa P, Gleisner A, et al
    Improved survival in rectal cancer patients who are treated with long-course versus short-course neoadjuvant radiotherapy: A propensity-matched analysis of the NCDB.
    J Surg Oncol. 2019;119:518-531.
    PubMed     Abstract available

  78. SCLAFANI F, Hesselberg G, Thompson SR, Truskett P, et al
    Multimodality treatment of oligometastatic anal squamous cell carcinoma: A case series and literature review.
    J Surg Oncol. 2019;119:489-496.
    PubMed     Abstract available

  79. SCHLICK CJR, Merkow RP, Bentrem DJ
    Nonresectional regional therapies for metastatic colorectal cancer to the liver.
    J Surg Oncol. 2019 Mar 1. doi: 10.1002/jso.25423.
    PubMed     Abstract available

  80. VUIJK FA, Hilling DE, Mieog JSD, Vahrmeijer AL, et al
    Response to the Letter to the Editor.
    J Surg Oncol. 2019;119:399.

    February 2019
  81. DE ANDRADE JP, Warner SG, Fong Y
    Treatment of metastatic colorectal cancer: innovations in surgical techniques.
    J Surg Oncol. 2019 Feb 27. doi: 10.1002/jso.25418.
    PubMed     Abstract available

  82. LEE RM, Cardona K, Russell MC
    Historical perspective: Two decades of progress in treating metastatic colorectal cancer.
    J Surg Oncol. 2019 Feb 26. doi: 10.1002/jso.25431.
    PubMed     Abstract available

  83. MELSTROM LG, Tzeng CD
    Metastatic colorectal cancer: The reality of the present and the optimism of the future.
    J Surg Oncol. 2019 Feb 26. doi: 10.1002/jso.25427.

  84. SANDHU J, Lavingia V, Fakih M
    Systemic treatment for metastatic colorectal cancer in the era of precision medicine.
    J Surg Oncol. 2019 Feb 25. doi: 10.1002/jso.25421.
    PubMed     Abstract available

  85. BLISS LA, Strong EA, Gamblin TC
    Surgical resectability of multisite metastatic colorectal cancer: Pushing the limits while appropriately selecting patients.
    J Surg Oncol. 2019 Feb 25. doi: 10.1002/jso.25419.
    PubMed     Abstract available

    January 2019
  86. FLYNN SM, Burchette RJ, Ghassemi M, Ratner O, et al
    Carnoy's solution fixation with compression significantly increases the number of lymph nodes yielded from colorectal cancer specimens.
    J Surg Oncol. 2019 Jan 16. doi: 10.1002/jso.25372.
    PubMed     Abstract available

  87. LEIJSSEN LGJ, Dinaux AM, Amri R, Taylor MS, et al
    Impact of intramural and extramural vascular invasion on stage II-III colon cancer outcomes.
    J Surg Oncol. 2019 Jan 15. doi: 10.1002/jso.25367.
    PubMed     Abstract available

  88. YU J, Li N, Tang Y, Wang X, et al
    Outcomes after hypofractionated stereotactic radiotherapy for colorectal cancer oligometastases.
    J Surg Oncol. 2019 Jan 4. doi: 10.1002/jso.25361.
    PubMed     Abstract available

  89. FIELDS AC, McCarty JC, Ma-Pak L, Lu P, et al
    New lymph node staging for rectal neuroendocrine tumors.
    J Surg Oncol. 2019;119:156-162.
    PubMed     Abstract available

    December 2018
  90. LINO-SILVA LS, Guzman-Lopez JC, Zepeda-Najar C, Salcedo-Hernandez RA, et al
    Overall survival of patients with colon cancer and a prolonged time to surgery.
    J Surg Oncol. 2018 Dec 24. doi: 10.1002/jso.25354.
    PubMed     Abstract available

  91. JIANG Z, Sun L, Yang W, Li J, et al
    Excessive expectations for carcinoembryonic antigen targeted fluorescent-guided surgery for sentinel lymph node detection in colorectal, pancreatic, and gastric cancer.
    J Surg Oncol. 2018 Dec 3. doi: 10.1002/jso.25318.

  92. CHAKEDIS J, Beal EW, Sun S, Galo J, et al
    Implementation and early outcomes for a surgeon-directed hepatic arterial infusion pump program for colorectal liver metastases.
    J Surg Oncol. 2018;118:1065-1073.
    PubMed     Abstract available

  93. SUAREZ J, Goicoetxea A, Gomez ML, Jimenez G, et al
    Impact of specific modes of circumferential resection margin involvement in rectal cancer local recurrence: A retrospective study.
    J Surg Oncol. 2018;118:1122-1128.
    PubMed     Abstract available

  94. REYNOLDS IS, McNamara DA, Kay EW, O'Neill B, et al
    The significance of mucin pools following neoadjuvant chemoradiotherapy for locally advanced rectal cancer.
    J Surg Oncol. 2018;118:1129-1134.
    PubMed     Abstract available

    November 2018
  95. MORIS D, Tsilimigras DI, Machairas N, Merath K, et al
    Laparoscopic synchronous resection of colorectal cancer and liver metastases: A systematic review.
    J Surg Oncol. 2018 Nov 27. doi: 10.1002/jso.25313.
    PubMed     Abstract available

  96. LIAO CK, Chiang JM, Tsai WS, You JF, et al
    Primary tumor location in stage III colon cancer has prognostic impact on subsequent liver metastasis.
    J Surg Oncol. 2018 Nov 8. doi: 10.1002/jso.25270.
    PubMed     Abstract available

  97. CHOUHAN H, Sammour T, Thomas ML, Moore JW, et al
    The interaction between BRAF mutation and microsatellite instability (MSI) status in determining survival outcomes after adjuvant 5FU based chemotherapy in stage III colon cancer.
    J Surg Oncol. 2018 Nov 6. doi: 10.1002/jso.25275.
    PubMed     Abstract available

    October 2018
  98. KUMAR NAN, Verma K, Shinde RS, Kammar P, et al
    Pulmonary metastasectomy of colorectal cancer origin: Evaluating process and outcomes.
    J Surg Oncol. 2018 Oct 17. doi: 10.1002/jso.25273.
    PubMed     Abstract available

    September 2018
  99. WATANABE A, Harimoto N, Araki K, Yoshizumi T, et al
    A new strategy based on fluorodeoxyglucose-positron emission tomography for managing liver metastasis from colorectal cancer.
    J Surg Oncol. 2018 Sep 27. doi: 10.1002/jso.25250.
    PubMed     Abstract available

  100. MARGONIS GA, Buettner S, Andreatos N, Wagner D, et al
    The prognosis of colorectal cancer liver metastases associated with inflammatory bowel disease: An exploratory analysis.
    J Surg Oncol. 2018 Sep 27. doi: 10.1002/jso.25251.
    PubMed     Abstract available

  101. VUIJK FA, Hilling DE, Mieog JSD, Vahrmeijer AL, et al
    Fluorescent-guided surgery for sentinel lymph node detection in gastric cancer and carcinoembryonic antigen targeted fluorescent-guided surgery in colorectal and pancreatic cancer.
    J Surg Oncol. 2018 Sep 14. doi: 10.1002/jso.25139.
    PubMed     Abstract available

  102. MANCEAU G, Mori A, Bardier A, Augustin J, et al
    Lymph node metastases in splenic flexure colon cancer: Is subtotal colectomy warranted?
    J Surg Oncol. 2018 Sep 13. doi: 10.1002/jso.25169.
    PubMed     Abstract available

  103. LI J, Gu J, Ma X, Li X, et al
    Development and validation of a nomogram for predicting survival in Chinese han patients with resected colorectal cancer.
    J Surg Oncol. 2018 Sep 9. doi: 10.1002/jso.25213.
    PubMed     Abstract available

  104. HU WH, Chen HH, Yen SL, Huang HY, et al
    Re: Increased expression of interleukin-23 associated with progression of colorectal cancer. Journal of Surgical Oncology 2017;115(2):208-212.
    J Surg Oncol. 2018;118:723.

  105. KERANMU A, Liu HN, Wu YC, Liu TT, et al
    A negative-doughnut distal resection margin less than 5 mm does not affect prognosis in rectal cancer.
    J Surg Oncol. 2018;118:536-543.
    PubMed     Abstract available

  106. TANG Y, Rao S, Yang C, Hu Y, et al
    Value of MRI morphologic features with pT1-2 rectal cancer in determining lymph node metastasis.
    J Surg Oncol. 2018;118:544-550.
    PubMed     Abstract available

    August 2018
  107. HENTZEN JEKR, de Jongh SJ, Hemmer PHJ, van der Plas WY, et al
    Molecular fluorescence-guided surgery of peritoneal carcinomatosis of colorectal origin: A narrative review.
    J Surg Oncol. 2018;118:332-343.
    PubMed     Abstract available

    July 2018
  108. KRUGER JAP, Fonseca GM, Makdissi FF, Jeismann VB, et al
    Evolution in the surgical management of colorectal liver metastases: Propensity score matching analysis (PSM) on the impact of specialized multidisciplinary care across two institutional eras.
    J Surg Oncol. 2018;118:50-60.
    PubMed     Abstract available

    June 2018
  109. LE SOUDER E, Azin A, Wood T, Hirpara D, et al
    The effect of a simultaneous versus a staged resection of metastatic colorectal cancer on time to adjuvant chemotherapy.
    J Surg Oncol. 2018 Jun 7. doi: 10.1002/jso.25122.
    PubMed     Abstract available

  110. SIDERAS K, Galjart B, Vasaturo A, Pedroza-Gonzalez A, et al
    Prognostic value of intra-tumoral CD8(+) /FoxP3(+) lymphocyte ratio in patients with resected colorectal cancer liver metastasis.
    J Surg Oncol. 2018 Jun 7. doi: 10.1002/jso.25091.
    PubMed     Abstract available

  111. ZAIMI I, Sparreboom CL, Lingsma HF, Doornebosch PG, et al
    The effect of age on anastomotic leakage in colorectal cancer surgery: A population-based study.
    J Surg Oncol. 2018 Jun 7. doi: 10.1002/jso.25108.
    PubMed     Abstract available

  112. LI J, Wang Y, Liu D, Zhou H, et al
    Multidimensional analyses of the learning curve for single-incision plus one port laparoscopic surgery for sigmoid colon and upper rectal cancer.
    J Surg Oncol. 2018;117:1386-1393.
    PubMed     Abstract available

  113. FONSECA GM, de Mello ES, Faraj SF, Kruger JAP, et al
    Prognostic significance of poorly differentiated clusters and tumor budding in colorectal liver metastases.
    J Surg Oncol. 2018;117:1364-1375.
    PubMed     Abstract available

  114. CHO MS, Park YY, Yoon J, Yang SY, et al
    MRI-based EMVI positivity predicts systemic recurrence in rectal cancer patients with a good tumor response to chemoradiotherapy followed by surgery.
    J Surg Oncol. 2018;117:1823-1832.
    PubMed     Abstract available

    May 2018
  115. CHOE EK, Yi JW, Chai YJ, Park KJ, et al
    Upregulation of the adipokine genes ADIPOR1 and SPP1 is related to poor survival outcomes in colorectal cancer.
    J Surg Oncol. 2018 May 14. doi: 10.1002/jso.25078.
    PubMed     Abstract available

  116. DUPRE A, Rehman A, Jones RP, Parker A, et al
    Validation of clinical prognostic scores for patients treated with curative-intent for recurrent colorectal liver metastases.
    J Surg Oncol. 2018;117:1330-1336.
    PubMed     Abstract available

  117. DINAUX AM, Leijssen LGJ, Bordeianou LG, Kunitake H, et al
    Effects of local multivisceral resection for clinically locally advanced rectal cancer on long-term outcomes.
    J Surg Oncol. 2018;117:1323-1329.
    PubMed     Abstract available

    April 2018
  118. MIYAMOTO E, Chen-Yoshikawa TF, Ueshima C, Yoshizawa A, et al
    Transition of the programmed death 1 pathway from the primary colorectal cancer to its corresponding pulmonary metastasis.
    J Surg Oncol. 2018 Apr 17. doi: 10.1002/jso.25045.
    PubMed     Abstract available

  119. MARQUES MC, C Ribeiro HS, Costa WL Jr., de Jesus VHF, et al
    Is primary sidedness a prognostic factor in patients with resected colon cancer liver metastases (CLM)?
    J Surg Oncol. 2018 Apr 2. doi: 10.1002/jso.25048.
    PubMed     Abstract available

  120. ZHONG A, Tian Y, Zhang H, Lai M, et al
    DNA hydroxymethylation of colorectal primary carcinoma and its association with survival.
    J Surg Oncol. 2018;117:1029-1037.
    PubMed     Abstract available

  121. BOGACH J, Tsai S, Zbuk K, Wong R, et al
    Quality of preoperative pelvic computed tomography (CT) and magnetic resonance imaging (MRI) for rectal cancer in a region in Ontario: A retrospective population-based study.
    J Surg Oncol. 2018;117:1038-1042.
    PubMed     Abstract available

  122. JUSTINGER C, Gruden J, Kouladouros K, Stravodimos C, et al
    Histopathological changes resulting from selective internal radiotherapy (SIRT).
    J Surg Oncol. 2018;117:1084-1091.
    PubMed     Abstract available

  123. MCCLUNEY SJ, Giakoustidis A, Segler A, Bissel J, et al
    Neutrophil: Lymphocyte ratio as a method of predicting complications following hepatic resection for colorectal liver metastasis.
    J Surg Oncol. 2018;117:1058-1065.
    PubMed     Abstract available

    March 2018
  124. BAGANTE F, Spolverato G, Beal E, Merath K, et al
    Impact of histological subtype on the prognosis of patients undergoing surgery for colon cancer.
    J Surg Oncol. 2018 Mar 25. doi: 10.1002/jso.25044.
    PubMed     Abstract available

  125. CHEN ST, Wu MC, Hsu TC, Yen DW, et al
    Comparison of outcome and cost among open, laparoscopic, and robotic surgical treatments for rectal cancer: A propensity score matched analysis of nationwide inpatient sample data.
    J Surg Oncol. 2018;117:497-505.
    PubMed     Abstract available

  126. LEE SY, Kim CH, Kim YJ, Kim HR, et al
    Prognostic significance of the distribution of lymph node metastasis in rectal cancer after neoadjuvant chemoradiation.
    J Surg Oncol. 2018;117:514-522.
    PubMed     Abstract available

  127. SESHADRI RA, Swaminathan R, Srinivasan A
    Laparoscopic versus open surgery for rectal cancer after neoadjuvant chemoradiation: Long-term outcomes of a propensity score matched study.
    J Surg Oncol. 2018;117:506-513.
    PubMed     Abstract available

  128. CABELLOS OLIVARES M, Labalde Martinez M, Torralba M, Rodriguez Fraile JR, et al
    C-reactive protein as a marker of the surgical stress reduction within an ERAS protocol (Enhanced Recovery After Surgery) in colorectal surgery: A prospective cohort study.
    J Surg Oncol. 2018;117:717-724.
    PubMed     Abstract available

  129. SUN Y, Zhang Y, Wu X, Lin H, et al
    Prognostic significance of neoadjuvant rectal score in locally advanced rectal cancer after neoadjuvant chemoradiotherapy and construction of a prediction model.
    J Surg Oncol. 2018;117:737-744.
    PubMed     Abstract available

  130. AMIKURA K, Akagi K, Ogura T, Takahashi A, et al
    The RAS mutation status predicts survival in patients undergoing hepatic resection for colorectal liver metastases: The results from a genetic analysis of all-RAS.
    J Surg Oncol. 2018;117:745-755.
    PubMed     Abstract available

  131. FISHER SB, Rafeeq S, Hess K, Grotz TE, et al
    Elevated brain natriuretic peptide (BNP) is an early marker for patients at risk for complications after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS + HIPEC).
    J Surg Oncol. 2018;117:685-691.
    PubMed     Abstract available

  132. PAK LM, Kemeny NE, Capanu M, Chou JF, et al
    Prospective phase II trial of combination hepatic artery infusion and systemic chemotherapy for unresectable colorectal liver metastases: Long term results and curative potential.
    J Surg Oncol. 2018;117:634-643.
    PubMed     Abstract available

  133. IHNAT P, Slivova I, Tulinsky L, Ihnat Rudinska L, et al
    Anorectal dysfunction after laparoscopic low anterior rectal resection for rectal cancer with and without radiotherapy (manometry study).
    J Surg Oncol. 2018;117:710-716.
    PubMed     Abstract available

    February 2018
  134. LE SOUDER EB, Azin A, Hirpara DH, Walker R, et al
    Considering the cost of a simultaneous versus staged approach to resection of colorectal cancer with synchronous liver metastases in a publicly funded healthcare model.
    J Surg Oncol. 2018 Feb 26. doi: 10.1002/jso.25020.
    PubMed     Abstract available

  135. WALKER R, Wood T, LeSouder E, Cleghorn M, et al
    Comparison of two novel staging systems with the TNM system in predicting stage III colon cancer survival.
    J Surg Oncol. 2018 Feb 23. doi: 10.1002/jso.25009.
    PubMed     Abstract available

  136. HUIJBERS A, van Pelt GW, Kerr RS, Johnstone EC, et al
    The value of additional bevacizumab in patients with high-risk stroma-high colon cancer. A study within the QUASAR2 trial, an open-label randomized phase 3 trial.
    J Surg Oncol. 2018 Feb 15. doi: 10.1002/jso.24998.
    PubMed     Abstract available

  137. IDREES K, Padmanabhan C, Liu E, Guo Y, et al
    Frequent BRAF mutations suggest a novel oncogenic driver in colonic neuroendocrine carcinoma.
    J Surg Oncol. 2018;117:284-289.
    PubMed     Abstract available

  138. GRAVANTE G, Stephenson JA, Elshaer M, Osman A, et al
    Analysis of outcomes achieved with squamous cell carcinomas of the anus in a single university hospital over the last two decades: Clinical response rate, relapse and survival of 190 patients.
    J Surg Oncol. 2018;117:269-274.
    PubMed     Abstract available

  139. TANI K, Shindoh J, Akamatsu N, Arita J, et al
    Management of disappearing lesions after chemotherapy for colorectal liver metastases: Relation between detectability and residual tumors.
    J Surg Oncol. 2018;117:191-197.
    PubMed     Abstract available

    December 2017
  140. KOZMAN MA, Fisher OM, Rebolledo BJ, Parikh R, et al
    CEA to peritoneal carcinomatosis index (PCI) ratio is prognostic in patients with colorectal cancer peritoneal carcinomatosis undergoing cytoreduction surgery and intraperitoneal chemotherapy: A retrospective cohort study.
    J Surg Oncol. 2017 Dec 19. doi: 10.1002/jso.24911.
    PubMed     Abstract available

  141. IWAI T, Yamada T, Koizumi M, Shinji S, et al
    Oxaliplatin-induced increase in splenic volume; irreversible change after adjuvant FOLFOX.
    J Surg Oncol. 2017;116:947-953.
    PubMed     Abstract available

  142. GOTO S, Hida K, Kawada K, Okamura R, et al
    Multicenter analysis of transanal tube placement for prevention of anastomotic leak after low anterior resection.
    J Surg Oncol. 2017;116:989-995.
    PubMed     Abstract available

  143. MARGONIS GA, Buettner S, Andreatos N, Sasaki K, et al
    Preoperative bevacizumab and volumetric recovery after resection of colorectal liver metastases.
    J Surg Oncol. 2017;116:1150-1158.
    PubMed     Abstract available

  144. AL-NAJAMI I, Drue HC, Steele R, Baatrup G, et al
    Dual energy CT - a possible new method to assess regression of rectal cancers after neoadjuvant treatment.
    J Surg Oncol. 2017;116:984-988.
    PubMed     Abstract available

    November 2017
  145. CHOI WJ, Moon JH, Min JS, Song YK, et al
    Real-time detection system for tumor localization during minimally invasive surgery for gastric and colon cancer removal: In vivo feasibility study in a swine model.
    J Surg Oncol. 2017 Nov 28. doi: 10.1002/jso.24922.
    PubMed     Abstract available

  146. CHOE EK, Park KJ, Ryoo SB, Moon SH, et al
    The impact of visceral adipose tissue amount on the adequacy of lymph node retrieval in colorectal cancer surgery.
    J Surg Oncol. 2017 Nov 9. doi: 10.1002/jso.24876.
    PubMed     Abstract available

  147. VAN DE PUTTE D, Van Daele E, Willaert W, Pattyn P, et al
    Effect of abdominopelvic sepsis on cancer outcome in patients undergoing sphincter saving surgery for rectal cancer.
    J Surg Oncol. 2017;116:722-729.
    PubMed     Abstract available

    October 2017
  148. JOSHI HM, Keller DS, Chand M
    Utilization of Indocyanine green to demonstrate lymphatic mapping in colon cancer.
    J Surg Oncol. 2017 Oct 29. doi: 10.1002/jso.24795.

  149. MANSO M, Schmelz J, Aloia T
    ERAS-Anticipated outcomes and realistic goals.
    J Surg Oncol. 2017;116:570-577.
    PubMed     Abstract available

    September 2017
  150. SASAKI K, Margonis GA, Andreatos N, Zhang XF, et al
    The prognostic utility of the "Tumor Burden Score" based on preoperative radiographic features of colorectal liver metastases.
    J Surg Oncol. 2017;116:515-523.
    PubMed     Abstract available

    May 2017
  151. LANGAN RC, Goldman DA, D'Angelica MI, DeMatteo RP, et al
    Recurrence patterns following irreversible electroporation for hepatic malignancies.
    J Surg Oncol. 2017;115:704-710.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Colorectal Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.